Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
DNLI Denali Therapeutics
- 16.440
- +0.380+2.37%
Close May 2 16:00 ET
- 16.440
- 0.0000.00%
Post 16:41 ET
2.39BMarket Cap-6.40P/E (TTM)
16.970High16.210Low1.12MVolume16.555Open16.060Pre Close18.58MTurnover0.86%Turnover RatioLossP/E (Static)145.24MShares33.33052wk High1.94P/B2.15BFloat Cap10.57052wk Low--Dividend TTM130.87MShs Float93.940Historical High--Div YieldTTM4.73%Amplitude10.570Historical Low16.606Avg Price1Lot Size
About Denali Therapeutics Company
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.
Company Profile
SymbolDNLI
Company NameDenali Therapeutics
Listing DateDec 8, 2017
Issue Price18.00
Founded2013
CEODr. Ryan J. Watts, PhD
MarketNASDAQ
Employees422
Fiscal Year Ends12-31
Address161 Oyster Point Boulevard
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-866-8547
Company Executives
- Name
- Position
- Salary
- Dr. Ryan J. Watts, PhD
- Director, President and Chief Executive Officer
- 6.56M
- Dr. Carole Ho, M.D.
- Chief Medical Officer and Head of Development
- 4.02M
- Dr. Alexander O. Schuth, M.D.
- Secretary, Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer
- 4.02M
- Dr. Vicki L. Sato, PhD
- Chairman of the Board
- 399.47K
- Steven E. Krognes
- Director
- 359.47K
- Nancy A. Thornberry
- Independent Director
- 374.47K
- Jennifer E. Cook
- Independent Director
- 369.47K
- Peter S. Klein
- Independent Director
- 389.43K
- Julian C. Baker
- Independent Director
- --
- Jay T. Flatley
- Independent Director
- 384.47K
- Erik Harris
- Independent Director
- 369.47K
- Dr. Marc Tessier-Lavigne, PhD
- Independent Director
- 371.97K
- Dr. David P. Schenkein, M.D.
- Independent Director
- 379.47K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now